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more computationally efﬁcient programming languages (such as
C) are preferred; concerns regarding model transparency using
compiled languages are best addressed via thorough documenta-
tion and model testing.
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OBJECTIVES: Gains in life expectancy have lead to aging popu-
lations with more chronic comorbidity. This study aims to
examine the impact of age and comorbidity on EQ-5D index
scores in a nationally representative sample of the U.S.
METHODS: The pooled 2001 and 2003 Medical Expenditure
Panel Survey (MEPS) was used. MEPS is a nationally represen-
tative survey of the U.S. civilian, noninstitutionalized population
based on self-report which collects detailed information on socio-
demographic characteristics, medical conditions and HRQL. The
total number of chronic conditions for each individual was cal-
culated based on ICD-9 codes. Spline regression was used to
allow for nonlinear age effects: individuals were separated into 4
quartiles based on age: 18–31; 32–44; 45–58; and >58 years.
Censored least absolute deviations (CLAD), Tobit and OLS
methods were used to regress EQ-5D index scores on age and
chronic comorbidity, controlling for income, gender, race, eth-
nicity, education, physical activity and smoking status. Interac-
tions between age and chronic conditions were also explored.
RESULTS: After controlling for chronic comorbidities and other
confounders, age was not statistically signiﬁcant except for those
>58 years and the magnitude of this coefﬁcient was very small
(coefﬁcient age >58 years = -0.0006). However, the coefﬁcients
for chronic comorbidities were highly statistically signiﬁcant
with large magnitudes for those with 2 chronic conditions
(coefﬁcient 2 chronic conditions = -0.16; coefﬁcient 9 chronic
conditions = -0.28). Having only one chronic condition was not
statistically signiﬁcant. The interaction between age and chronic
comorbidity was signiﬁcant, but the deleterious impact of their
interaction was largely dominated by the existence and number
of chronic conditions. CONCLUSIONS: Chronic conditions
have a signiﬁcant deleterious impact on EQ-5D index scores
regardless of age. The negative impact of age on EQ-5D
index scores may be due to the existence and degree of chronic
comorbidity.
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OBJECTIVES: To estimate WTP (€, 2006 value) per incremental
quality-adjusted life-year (QALY) gained for a future health tech-
nology when compared to the current technology in the treat-
ment of a particular disease. Secondly, WTP for incremental
life-year gained (LYG), and WTP for average QALY and LY were
estimated. METHODS: For the ﬁrst time in the Finnish setting,
CV was used to establish WTP for health beneﬁts that do not
have market prices. A postal survey including 8 diseases (1092
cases in total) with dichotomous choice (DC) type questions was
carried out to clinicians (N 197) and political decision makers (N
225). Based on the answers with varying costs for health beneﬁt,
aggregate demand functions (ADF) were drawn and the mean
WTP for particular beneﬁt in particular disease was estimated as
the area under ADF. As a new innovation, the potential future
order of disease priority in terms of WTP was established by
estimating cumulative marginal changes (CMC) in ADF. The care
costs and utilities were obtained from recent Finnish literature.
Discounting with 5% and 0% was done due to the life-time
perspectives. RESULTS: The mean WTP per incremental QALY
gained with 15D/EQ-5D utilities were the following (CMCs are
in the parentheses): neurological disturbance €420,921/46,8004
(€147,653/164,168), metabolic disturbance €320,974/333,961
(€118,823/123,631), cancer €127,937/138,308 (€61,611/
66,604), dementia €100,536/107,731 (€40,830/43,731),
paraplegia €124,544/563,41 (€35,013/15,839), coronary heart
disease €48,381/50,928 (€15,191/15,989), type 1 diabetes
€107,114/548,63 (€19,989/10,238), and narcomaniac €30,859/
45,106 (€7,705/14,231). WTPs for incremental LYG, average
QALY and LY were lower. The difference between EQ-5D and
15D WTP exceeded 10% in paraplegia, diabetes, narcomaniacs,
and neurological disease. This demonstrated that the results
obtained using different utility tools differ even in the ADF-
setting. CONCLUSIONS: Depending on the disease and utility
tool, CV based on DCs seems to result to different ADFs and
WTPs. By estimating CMCs from ADFs, potential future order
for diseases is estimated.
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No population norms for any generic health related quality of life
questionnaire are currently available in Poland. OBJECTIVES:
To measure the health of a representative sample of the general
population of Poland by using EuroQol questionnaire.
METHODS: Visitors of patients in seven medical centers in
Warsaw, Skierniewice and Pulawy, aged 18 and over, were inter-
viewed during Polish EQ-5D valuation study. Stratiﬁed quota
sampling was used. Respondents completed EQ-5D question-
naire and provided information on age, sex, marital state, edu-
cation, employment, income, housing tenure, medical history
and smoking behaviour. The interviews took place since Febru-
ary till May 2008. RESULTS: The ﬁnal sample comprising 317
subjects (62% Warsaw residents) was representative of the
general population with respect to age and sex. A moderate
problem on at least one dimension was reported by 57% respon-
dents, whereas only 4.7% of respondents reported any extreme
problem. Forty percent of respondents reported any problems
with pain or discomfort, 38% with anxiety or depression, 16%
with mobility, 13% with usual activities and 3% with self care.
The mean state of health recorded on the visual analogue scale
was 81.6 (SD 14.4). The mean VAS value decreased from about
87 and 91 in the youngest age group to 67 and 72 in the oldest
age group, in men and women respectively. CONCLUSIONS:
Pain and anxiety are commonly reported in Polish society.
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